Genkyotex S A
Geneva, Switzerland · Health and Medical
We built this page from public sources.
Do you work at Genkyotex S A?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Genkyotex S A is a Health and Medical company based in Geneva, Switzerland, founded in 2006, with 2-10 employees. Genkyotex S A's profile is verified on Enterprise League.
Overview
Genkyotex has become a wholly owned subsidiary of Calliditas and have been delisted from the Euronext stock exchanges.
Genkyotex’s lead product candidate, setanaxib, is a first-in-class NOX inhibitor that targets NOX 1 and NOX 4, which are major drivers of fibrogenesis in multiple organs. In Q4 2021, Calliditas plans to initiate a 52-week, randomized, placebo-controlled, double-blind, trial with an adaptive phase 2b/3 design with setanaxib in 318 patients with primary biliary cholangitis (PBC). As previously announced in August 2021, Calliditas received FDA fast track designation for setanaxib in PBC. Calliditas will also initiate a Phase 2 proof-of-concept study in head and neck cancer in 2021, which will investigate the administration of setanaxib in conjunction with immunotherapy targeting cancer associated fibroblasts (CAFs).
Follow @Calliditas Therapeutics for updates on future developments: https://www.linkedin.com/company/calliditas-therapeutics/
Contact Details
info@calliditas.se
Geneva, Switzerland
Founded
2006
Company Type
Private Limited Company
Employees
2-10
Categories
Companies teams usually look at after Genkyotex S A
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.